351 related articles for article (PubMed ID: 16987075)
1. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV.
Łapinski TW; Wiercińska-Drapało A; Panasiuk A; Kovalchuk O
Adv Med Sci; 2007; 52():109-13. PubMed ID: 18217400
[TBL] [Abstract][Full Text] [Related]
4. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
[TBL] [Abstract][Full Text] [Related]
6. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
Panasiuk A; Parfieniuk A; Zak J; Flisiak R
Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
[TBL] [Abstract][Full Text] [Related]
7. Investigation of apoptotic markers among human immunodeficiency virus (HIV-1) infected individuals.
Ramalingam S; Kannangai R; Abraham OC; Subramanian S; Rupali P; Pulimood SA; Jesudason MV; Sridharan G
Indian J Med Res; 2008 Dec; 128(6):728-33. PubMed ID: 19246796
[TBL] [Abstract][Full Text] [Related]
8. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
[TBL] [Abstract][Full Text] [Related]
9. Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.
Guzmán-Fulgencio M; Berenguer J; García-Álvarez M; Micheloud D; C López J; Cosín J; Fernández de Castro I; Catalán P; Miralles P; Resino S
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1213-21. PubMed ID: 21442358
[TBL] [Abstract][Full Text] [Related]
10. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
Song le H; Binh VQ; Duy DN; Bock TC; Kremsner PG; Luty AJ; Mavoungou E
J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
Jun EJ; Han JY; Sun HS
Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
[TBL] [Abstract][Full Text] [Related]
12. [An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients].
DU XF; Zhang YH; Ma LN; Yan HP; Chen XY; Wu H
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):345-8. PubMed ID: 18510845
[TBL] [Abstract][Full Text] [Related]
13. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
14. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
17. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
18. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
Daar ES; Lynn H; Donfield S; Gomperts E; O'Brien SJ; Hilgartner MW; Hoots WK; Chernoff D; Arkin S; Wong WY; Winkler CA;
J Infect Dis; 2001 Feb; 183(4):589-95. PubMed ID: 11170984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
